AI summary by TwinMind
Should you donate your DNA to help cure diseases? - Greg Foot
TED-Ed
5m 48s
Traditional Drug Development Challenges
- Drug development extremely slow, expensive process
- Significant trial and error required for conditions like multiple sclerosis, heart disease
- Only small proportion of diseases have available drugs
- Historical discovery often by chance, then identification of active chemicals
Evolution of Drug Development Understanding
- Early medicines discovered accidentally by natural philosophers
- Pharmaceutical companies converted identified chemicals into drugs
- Initially didn't understand mechanism of action
- Breakthrough: diseases occur when protein "molecular machines" malfunction
- Modern approach: target disruptive proteins to treat disease
- Slow progress identifying therapeutic targets for most diseases
Genomic Approach to Drug Discovery
- Researchers shifting focus to DNA as genetic instruction manual
- Goal: identify small genome changes leading to faulty protein production
- Challenge: DNA massive, each disease involves hundreds/thousands of proteins
- Solution: compare multiple genomes to spot patterns
- Process: analyze people with same untreatable disease → find shared genetic changes → identify faulty proteins → discover new therapeutic targets
Three Drug Development Pathways
Option 1: Repurposing Existing Drugs
- Check if new target protein linked to different treatable disease
- Existing drug for that disease may work for new condition
- Requires clinical trial validation
Option 2: Reviving Failed Drugs
- Identify if target protein linked to disease with promising but ultimately failed drug
- Failed drug's promise may have come from targeting this protein
- May work for new disease, requires clinical trial
Option 3: Novel Drug Design
- Brand new protein target never identified before
- Involves AI machine learning, advanced chemistry
- Most time-consuming, expensive, effort-intensive approach
Research Potential and Statistics
- 1 in 5 body proteins have or likely to have bindable drugs
- Common diseases involve hundreds/thousands of proteins
- High probability existing drugs already available for some targets
- Success depends on finding new therapeutic targets
Data Requirements and Crowdsourcing
- Researchers need genetic data + health history data
- Purpose: compare genomes of people with similar conditions
- Medical crowdsourcing asking for personal data donation, not money
Data Privacy and Access Concerns
Key Stakeholders
- Healthcare providers: using genetic analysis for personalized patient care
- Private consumer genetic testing companies
- Some companies already sold genetic data to pharmaceutical companies (with consent)
Ethical Considerations
- Question: should pharmaceutical companies offer cheaper drugs to data contributors?
- Recommendation: research organizations requesting data to understand their policies
- Important to verify data protection measures and usage intentions
Future Implications
- Genomics could significantly reduce drug development time and cost
- Potential to develop treatments for currently untreatable diseases
- Individual decisions needed regarding data sharing participation
